Icon Wealth Partners’s Kyntra Bio KYNB Stock Holding History

Icon Wealth Partners’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-14	Closed	-$19K	–	368
2019 Q1	$19K	Buy	+14	New	+$19K	0.01%	563

Other funds holding KYNB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Icon Wealth Partners's KYNB Position: Q2 2019 in Review

Icon Wealth Partners sold out of Kyntra Bio (KYNB) in Q2 2019, closing a stake of 14 shares — an estimated $19K sold.

Icon Wealth Partners first reported a position in KYNB in Q1 2019 and held it in 1 quarter. The position peaked at $19K in Q1 2019. 190 funds tracked by Wall St. Rank hold KYNB as of Q2 2019.

Icon Wealth Partners reported no remaining Kyntra Bio position as of Q2 2019 after selling out during the quarter.
Icon Wealth Partners sold 14 Kyntra Bio shares in Q2 2019, an estimated $19K.
Icon Wealth Partners first reported a position in Kyntra Bio in Q1 2019 and held it in 1 quarter.
Icon Wealth Partners's Kyntra Bio position peaked at $19K in Q1 2019.
190 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2019.

Based on Icon Wealth Partners's 13F filing for Q2 2019, filed 13 Aug 2019.